[1]
H. Meriyani, D. A. Sanjaya, R. A. Juanita, N. B. Siada, N. Chusna, and F. G. Ketupapa, “Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review”, Borneo J Pharm, vol. 8, no. 1, pp. 33–48, Feb. 2025, doi: 10.33084/bjop.v8i1.7913.